FAM120C
gene geneOn this page
Also known as ORF34FLJ20506
Summary
FAM120C (family with sequence similarity 120 member C, HGNC:16949) is a protein-coding gene on chromosome Xp11.22, encoding Constitutive coactivator of PPAR-gamma-like protein 2 (Q9NX05).
This gene encodes a potential transmembrane protein and lies in a region where mutations and deletions have been associated with intellectual disability and autism. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 54954 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 205 total — 3 pathogenic, 1 likely-pathogenic
- MANE Select transcript:
NM_017848
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16949 |
| Approved symbol | FAM120C |
| Name | family with sequence similarity 120 member C |
| Location | Xp11.22 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | ORF34, FLJ20506 |
| Ensembl gene | ENSG00000184083 |
| Ensembl biotype | protein_coding |
| OMIM | 300741 |
| Entrez | 54954 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000328235, ENST00000375180, ENST00000477084, ENST00000497680
RefSeq mRNA: 3 — MANE Select: NM_017848
NM_001300788, NM_017848, NM_198456
CCDS: CCDS14356, CCDS55421, CCDS75987
Canonical transcript exons
ENST00000375180 — 16 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001295956 | 54091312 | 54091426 |
| ENSE00001314426 | 54085715 | 54085916 |
| ENSE00001316357 | 54087755 | 54087964 |
| ENSE00001364079 | 54157689 | 54157771 |
| ENSE00001365333 | 54135528 | 54135604 |
| ENSE00001368219 | 54134831 | 54135111 |
| ENSE00001369447 | 54133773 | 54134046 |
| ENSE00001369586 | 54151245 | 54151373 |
| ENSE00001369910 | 54159370 | 54159616 |
| ENSE00001370367 | 54116545 | 54116794 |
| ENSE00001370881 | 54136491 | 54136590 |
| ENSE00001381626 | 54132692 | 54132863 |
| ENSE00001466014 | 54068324 | 54073287 |
| ENSE00003558903 | 54080232 | 54080289 |
| ENSE00003591082 | 54081322 | 54081460 |
| ENSE00003850750 | 54182500 | 54183254 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 90.45.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.1618 / max 165.0067, expressed in 1794 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 199384 | 13.4778 | 1768 |
| 199385 | 4.6841 | 1430 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| inferior vagus X ganglion | UBERON:0005363 | 90.45 | gold quality |
| ventral tegmental area | UBERON:0002691 | 88.85 | gold quality |
| medial globus pallidus | UBERON:0002477 | 87.84 | gold quality |
| subthalamic nucleus | UBERON:0001906 | 87.65 | gold quality |
| globus pallidus | UBERON:0001875 | 87.48 | gold quality |
| superior vestibular nucleus | UBERON:0007227 | 87.43 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 85.56 | gold quality |
| cerebellar vermis | UBERON:0004720 | 84.78 | silver quality |
| mucosa of paranasal sinus | UBERON:0005030 | 84.28 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 84.23 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.76 | gold quality |
| dorsal plus ventral thalamus | UBERON:0001897 | 83.29 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 82.65 | gold quality |
| lateral globus pallidus | UBERON:0002476 | 82.51 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 82.47 | gold quality |
| substantia nigra pars compacta | UBERON:0001965 | 82.46 | gold quality |
| ventricular zone | UBERON:0003053 | 82.31 | gold quality |
| corpus callosum | UBERON:0002336 | 82.30 | gold quality |
| pons | UBERON:0000988 | 82.15 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 82.06 | gold quality |
| pericardium | UBERON:0002407 | 81.73 | silver quality |
| nipple | UBERON:0002030 | 81.41 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 81.26 | silver quality |
| oocyte | CL:0000023 | 80.96 | gold quality |
| medulla oblongata | UBERON:0001896 | 80.72 | gold quality |
| corpus epididymis | UBERON:0004359 | 80.57 | gold quality |
| saphenous vein | UBERON:0007318 | 80.52 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.45 | gold quality |
| caput epididymis | UBERON:0004358 | 80.39 | gold quality |
| renal medulla | UBERON:0000362 | 79.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 5.69 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
191 targeting FAM120C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5193 | 100.00 | 67.26 | 1744 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-3120-5P | 100.00 | 65.56 | 965 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
Literature-anchored findings (GeneRIF, showing 2)
- Xp11.22 deletion including genes PHF8, FAM120C and WNK3 may be involved in the pathogenesis of autism. (PMID:18498374)
- FAM120C is a novel candidate gene for autism spectrum disorder based on genetic evidence and the brain expression pattern. (PMID:25258334)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fam120c | ENSDARG00000019205 |
| mus_musculus | Fam120c | ENSMUSG00000025262 |
| rattus_norvegicus | Fam120c | ENSRNOG00000062231 |
Paralogs (2): FAM120A (ENSG00000048828), FAM120B (ENSG00000112584)
Protein
Protein identifiers
Constitutive coactivator of PPAR-gamma-like protein 2 — Q9NX05 (reviewed: Q9NX05)
Alternative names: Protein FAM120C, Tumor antigen BJ-HCC-21
All UniProt accessions (2): Q9NX05, F8W881
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed at low levels in a number of tissues.
Similarity. Belongs to the constitutive coactivator of PPAR-gamma family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NX05-1 | 1 | yes |
| Q9NX05-2 | 2 |
RefSeq proteins (3): NP_001287717, NP_060318, NP_940858 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026784 | Coact_PPARg | Family |
| IPR029060 | PIN-like_dom_sf | Homologous_superfamily |
UniProt features (17 total): compositionally biased region 6, region of interest 3, modified residue 2, splice variant 2, sequence variant 2, chain 1, cross-link 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NX05-F1 | 69.02 | 0.44 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 58, 977, 1042
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 143 (showing top):
E2F_Q4_01, TGCGCANK_UNKNOWN, E2F_Q3, YY1_02, AAAGGGA_MIR204_MIR211, TGANTCA_AP1_C, GATA1_03, E2F1_Q3, CTTTGTA_MIR524, E2F_Q6_01, PARENT_MTOR_SIGNALING_UP, TGGAAA_NFAT_Q4_01, ACTWSNACTNY_UNKNOWN, GCCATNTTG_YY1_Q6, TCCCRNNRTGC_UNKNOWN
GO Biological Process (0):
GO Molecular Function (1): RNA binding (GO:0003723)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleic acid binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
702 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM120C | PHF8 | Q9UPP1 | 851 |
| FAM120C | WNK3 | Q9BYP7 | 813 |
| FAM120C | DNAJC28 | Q9NX36 | 720 |
| FAM120C | MPLKIP | Q8TAP9 | 719 |
| FAM120C | A0A090J7P6 | A0A090J7P6 | 715 |
| FAM120C | ERCC5 | P28715 | 668 |
| FAM120C | SUGCT | Q9HAC7 | 608 |
| FAM120C | CTTNBP2 | Q8WZ74 | 593 |
| FAM120C | TAX1BP1 | Q86VP1 | 587 |
| FAM120C | CWC15 | Q9P013 | 571 |
| FAM120C | EPAS1 | Q99814 | 529 |
| FAM120C | FAM3B | P58499 | 521 |
| FAM120C | CENPVL1 | A0A0U1RR11 | 480 |
| FAM120C | ASZ1 | Q8WWH4 | 479 |
| FAM120C | PCBP1 | Q15365 | 474 |
IntAct
22 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| P4HA3 | FAM171A2 | psi-mi:“MI:0914”(association) | 0.640 |
| HNRNPC | CASC3 | psi-mi:“MI:0914”(association) | 0.530 |
| TFCP2 | FAM120C | psi-mi:“MI:0915”(physical association) | 0.370 |
| Rpl35 | RPS6 | psi-mi:“MI:0914”(association) | 0.350 |
| SEC16A | NCOR2 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPU | psi-mi:“MI:0914”(association) | 0.350 | |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| BMI1 | MEIS3P1 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPH1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| PURG | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM120A | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| CCL3 | KRBA1 | psi-mi:“MI:0914”(association) | 0.350 |
| HNRNPC | APOBEC3DE | psi-mi:“MI:0914”(association) | 0.350 |
| PABPC5 | APOBEC3DE | psi-mi:“MI:0914”(association) | 0.350 |
| YBX1 | NOP56 | psi-mi:“MI:0914”(association) | 0.350 |
| MYO6 | GIPC1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| LIN28B | MEX3A | psi-mi:“MI:2364”(proximity) | 0.270 |
| SMNDC1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| SUMO1 | CHD2 | psi-mi:“MI:0914”(association) | 0.000 |
BioGRID (210): BANP (Two-hybrid), FAM120C (Affinity Capture-MS), TFCP2 (Two-hybrid), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-RNA), FAM120C (Proximity Label-MS), FAM120C (Affinity Capture-MS), FAM120C (Affinity Capture-MS), FAM120C (Proximity Label-MS), FAM120C (Proximity Label-MS), FAM120C (Affinity Capture-MS)
ESM2 similar proteins: A0JPH4, A2RSY1, A6H7H1, A6QNT4, B2RUR8, B5X165, D2HNW6, F1R7R1, O15550, O54828, O70546, O75916, O88974, P49140, P49805, P53349, P55265, P55266, Q13191, Q13233, Q15047, Q2YDD2, Q3KR73, Q3TTA7, Q5PQS6, Q5R6Y9, Q60698, Q62925, Q6A0A9, Q6DEZ2, Q6GQL0, Q6GQQ9, Q6NXD8, Q6RI63, Q80U62, Q86XL3, Q8C3F2, Q8K2L8, Q8K4S7, Q8N5Y2
Diamond homologs: A6H7H1, Q5T035, Q6A0A9, Q6DEZ2, Q8C3F2, Q96EK7, Q9NX05, Q9NZB2, A6QNT4, Q6RI63
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 34 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | 6 | 24.6× | 2e-05 |
| mRNA Polyadenylation | 5 | 22.0× | 2e-04 |
| mRNA Splicing - Major Pathway | 6 | 16.4× | 1e-04 |
| Dengue Virus-Host Interactions | 5 | 11.4× | 3e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
205 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 1 |
| Uncertain significance | 65 |
| Likely benign | 6 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (4)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2685088 | GRCh37/hg19 Xp11.22(chrX:53954419-54291347)x0 | Pathogenic |
| 395687 | GRCh37/hg19 Xp22.33-q28(chrX:70297-155255792) | Pathogenic |
| 685927 | GRCh37/hg19 Xp11.22(chrX:53384424-54103704)x2 | Pathogenic |
| 1526801 | GRCh37/hg19 Xp11.22(chrX:53797930-54608609) | Likely pathogenic |
SpliceAI
2768 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:54072997:C:A | donor_gain | 1.0000 |
| X:54073003:T:TA | donor_gain | 1.0000 |
| X:54080226:ACTT:A | donor_loss | 1.0000 |
| X:54080227:CTT:C | donor_loss | 1.0000 |
| X:54080228:TTA:T | donor_loss | 1.0000 |
| X:54080229:TA:T | donor_loss | 1.0000 |
| X:54080230:A:AC | donor_gain | 1.0000 |
| X:54080230:ACTT:A | donor_loss | 1.0000 |
| X:54080230:ACTTG:A | donor_gain | 1.0000 |
| X:54080231:C:CA | donor_gain | 1.0000 |
| X:54080231:CT:C | donor_gain | 1.0000 |
| X:54080231:CTT:C | donor_gain | 1.0000 |
| X:54080231:CTTG:C | donor_gain | 1.0000 |
| X:54080231:CTTGC:C | donor_gain | 1.0000 |
| X:54080299:G:GC | acceptor_gain | 1.0000 |
| X:54087734:AGCAG:A | donor_gain | 1.0000 |
| X:54087808:G:C | donor_gain | 1.0000 |
| X:54091307:CTCA:C | donor_loss | 1.0000 |
| X:54091308:TCA:T | donor_loss | 1.0000 |
| X:54091310:A:AC | donor_gain | 1.0000 |
| X:54091310:AC:A | donor_gain | 1.0000 |
| X:54091310:ACCTT:A | donor_loss | 1.0000 |
| X:54091311:C:CG | donor_loss | 1.0000 |
| X:54091311:C:CT | donor_gain | 1.0000 |
| X:54091311:CC:C | donor_gain | 1.0000 |
| X:54091311:CCT:C | donor_gain | 1.0000 |
| X:54091311:CCTT:C | donor_gain | 1.0000 |
| X:54091311:CCTTG:C | donor_gain | 1.0000 |
| X:54091422:TGTAC:T | acceptor_gain | 1.0000 |
| X:54091423:GTAC:G | acceptor_gain | 1.0000 |
AlphaMissense
7091 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:54081396:C:A | W968C | 1.000 |
| X:54081396:C:G | W968C | 1.000 |
| X:54081398:A:G | W968R | 1.000 |
| X:54081398:A:T | W968R | 1.000 |
| X:54081427:A:G | L958P | 1.000 |
| X:54087844:A:G | W850R | 1.000 |
| X:54087844:A:T | W850R | 1.000 |
| X:54087862:A:G | W844R | 1.000 |
| X:54087862:A:T | W844R | 1.000 |
| X:54087867:A:T | V842D | 1.000 |
| X:54087876:C:A | G839V | 1.000 |
| X:54087876:C:T | G839D | 1.000 |
| X:54087877:C:G | G839R | 1.000 |
| X:54087878:A:C | C838W | 1.000 |
| X:54087879:C:T | C838Y | 1.000 |
| X:54087880:A:G | C838R | 1.000 |
| X:54087882:G:T | A837D | 1.000 |
| X:54087885:T:A | D836V | 1.000 |
| X:54087887:A:C | N835K | 1.000 |
| X:54087887:A:T | N835K | 1.000 |
| X:54087891:G:T | A834D | 1.000 |
| X:54087900:G:T | A831D | 1.000 |
| X:54087912:C:T | G827E | 1.000 |
| X:54116558:A:G | C767R | 1.000 |
| X:54116581:A:T | V759D | 1.000 |
| X:54116622:A:C | C745W | 1.000 |
| X:54116623:C:T | C745Y | 1.000 |
| X:54116624:A:G | C745R | 1.000 |
| X:54116629:A:G | L743P | 1.000 |
| X:54116632:A:G | F742S | 1.000 |
dbSNP variants (sampled 300 via entrez): RS1000013251 (X:54162129 T>C), RS1000107714 (X:54176945 T>C), RS1000192837 (X:54109946 T>A), RS1000218077 (X:54128717 T>C), RS1000249354 (X:54128120 C>T), RS1000287648 (X:54093579 A>G), RS1000339751 (X:54182377 T>C), RS1000363880 (X:54104513 T>C), RS1000396452 (X:54103895 A>G), RS1000446354 (X:54161762 G>A), RS1000585095 (X:54126540 C>T), RS1000695911 (X:54101469 C>T), RS1000709699 (X:54180139 G>T), RS1000726684 (X:54101071 A>G), RS1000797899 (X:54111998 A>T)
Disease associations
OMIM: gene MIM:300741 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Benzo(a)pyrene | decreases expression, increases methylation | 2 |
| Tobacco Smoke Pollution | decreases expression | 2 |
| Aflatoxin B1 | decreases methylation | 2 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| benzo(e)pyrene | affects methylation | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| nickel sulfate | increases expression | 1 |
| dinophysistoxin 1 | decreases expression | 1 |
| abrine | decreases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Lead | decreases expression | 1 |
| Methapyrilene | affects methylation | 1 |
| Quercetin | increases expression | 1 |
| Ribonucleotides | affects binding | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.